Neuroendoscopy Market - By Product (Rigid Neuroendoscopes, Flexible Neuroendoscopes), By Usability (Reusable Neuroendoscopes, Disposable Neuroendoscopes), By Patient (Adult, Pediatric), By Application, By End-use & Forecast, 2023 – 2032

Neuroendoscopy Market Size

Neuroendoscopy Market size was valued at around USD 142.7 million in 2022 and is anticipated to grow at a CAGR of over 5.4% between 2023 and 2032. This incremental growth rate is owing to increasing prevalence of neurological disorders, coupled with ageing population and technological advancements in neuroendoscopy devices.
 

Growing number of brain tumor cases across the globe will result in augmenting the demand and adoption rate of neuroendoscopy surgical procedures. Moreover, several types of tumors such as acoustic neuroma and craniopharyngioma among others will further increase the number of neurosurgery procedures, fueling the neuroendoscopy industry expansion.

Neuroendoscopy is a minimally invasive surgical procedure used to diagnose and treat neurological conditions within the brain, spinal cord, or surrounding structures. These devices are incorporated with thin, flexible tube with a light source and a camera attached to its tip to access the target area.

Lack of skilled healthcare professionals in the developing regions will be a major market impeding factor. Continuous innovations and technological advancements in neuroendoscopy devices have increased a constant demand for extremely skilled professionals. Understanding and successfully implementing innovative technologies is crucial factor for healthcare professionals and must possess the necessary skill while performing endoscopy procedures. Therefore, highly skilled personnel are required to serve the purpose in most efficient and effective way. However, there has been a continuous dearth in availability of skilled personnel in neuroendoscopy market. Additionally, lack of healthcare resources along with dearth of skilled healthcare professionals is escalating the burden of chronic conditions globally. Thus, low accessibility to diagnostic services such as neuroendoscopy will hamper business growth over coming years.

COVID-19 Impact

The global outbreak of COVID-19 had an unfavorable influence on the neuroendoscopy market. Governments across the globe had imposed restrictions on movement and obligatory lockdowns. The subsequent travel restrictions and quarantine guidelines have led to substantial disruptions in availability & access to wide range of healthcare services. Majority of the neurological procedures do not qualify as medical emergency services and hence were not easily accessible to the individuals during the pandemic. Although, with the steady decrease in coronavirus cases, restrictions pertaining to non-urgent medical services in several countries were lifted, resulting in a rise in the patient influx related to neurological diseases at several healthcare facilities. Thus, the COVID-19 pandemic had a negative impact on the neuroendoscopy industry, however owing to decreased COVID-19 patient influx, technological advancements, resining healthcare expenditure and government initiatives, the industry is estimated to witness a lucrative growth rate in the coming years.

Neuroendoscopy Market Trends

Recent technological advancements and developments in manufacturing of novel neuroendoscopy devices will boost the market growth in the near future. Several novel neuroendoscopy devices and new technologies have significantly impacted the neuroendoscopy industry growth owing to enhancement in fiber optics and imaging, and innovation in new surgical approaches. Continuous upgradation of technology allows introduction of numerous types of technologically intensive neuroendoscopes that assist neurosurgeons in conducting complicated brain and central nervous system related surgeries. Development of such neuroendoscopes has resulted in growing convenience and ease of performing surgical procedures accelerating the business growth across the globe.

Neuroendoscopy Market Analysis

Based on product, the market is segmented as rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes is further bifurcated as rigid fiberscopes and rigid videoscopes. Rigid neuroendoscopes dominated the neuroendoscopy market in 2022 accounting for more than 66% of the total market share. These instruments enable direct visualization of the diseased area when passed through a natural orifice in the body. Some of the major benefits offered by rigid endoscopes include enhanced image quality, improved manoeuvrability, access to deep-seated regions and efficient irrigation and suction among others. Additionally, these products can accommodate various surgical instruments and offer more durability making them suitable for repeated use and sterilization.

Based on application, the market is segmented as transnasal neuroendoscopy, intraventricular neuroendoscopy and transcranial neuroendoscopy. The intraventricular neuroendoscopy accounted for major neuroendoscopy market revenue with over USD 73 million in 2022. This high market revenue is owing to increasing prevalence of neurological disorders, brain tumour and biopsy coupled with rising geriatric population among others. Intraventricular neuroendoscopy is a minimally invasive surgical procedure that involves using a small endoscope to visualize and treat various neurological conditions within the ventricles of the brain. Intraventricular tumours, such as colloid cysts or ependymomas, can be accessed and biopsied using neuroendoscopy. The neuroendoscope allows for a clear view of the tumour, aiding in accurate sampling for pathological analysis.

Based on usability, the neuroendoscopy market is segmented as reusable neuroendoscopes and disposable neuroendoscopes. The reusable neuroendoscopes segment held a dominant market revenue of USD 123 million in 2022. This high market share is owing to several clinical benefits offered by reusable neuroendoscopes in minimally invasive surgeries, diagnosis and treatment of several chronic ailments, etc. Increasing preference and demand of reusable neuroendoscopes over conventional instruments owing to low maintenance cost along with less time for decontamination will enhance the segmental growth. These instruments can be sterilized and used in multiple procedures, offer several benefits in clinical practice. Reusable neuroendoscopes are more cost effective and contribute to environmental sustainability by reducing medical waste. Therefore, easy availability and accessibility coupled increased demand for minimally invasive surgery has resulted in enhanced product.

Based on patient, the market is segmented as adult and pediatric. The adult segment held a dominant market share in 2022 and is forecasted to grow at 5.0% CAGR by 2032. Ageing population is one of the primary factors driving the neuroendoscopy market growth. Rising age related disorders among geriatric population further require endoscopy for disease diagnosis. Elderly individuals are more prone to suffer from one or multiple diseases thereby stimulating the demand for neuroendoscopy. For instance, according to the American Society of Clinical Oncology (ASCO), in 2020, around 308,102 adults were estimated to be diagnosed with brain tumour and is expected to increase in the near future. Hence, ageing population and passive life style will lead to increase in incidences of health disorders thereby, accelerating the demand for neuroendoscopes.

Based on end-use, the neuroendoscopy market is segmented as hospitals, ambulatory surgical centers, diagnostic centers, and others. The hospital segment held the highest industry share in 2022 and is projected to grow at 4.9% CAGR from 2023-2032. This high industry share is owing to the availability of advanced neuroendoscopy instruments for the diagnosis and treatment of varied chronic ailments. Enhanced operability and accessibility to comprehensive range of treatment is expected to drive the market growth. Presence of state-of-art facilities in the hospitals, insurance coverage to the patients, increasing number of neuro surgeries along with presence of skilled healthcare professionals will fuel the segment growth. Owing to these developments along with the rising number of diseases population, the demand for neuroendoscopy has significantly increased in hospitals.Thus, accessibility to better treatment & diagnosis coupled with the rising prevalence of chronic disorders will boost patient visits to hospitals, thereby propelling the segmental revenue.

U.S. Neuroendoscopy market is predicted to reach around USD 80.1 million by 2032. This market share is attributable to numerous variables including the presence of key market players, an increase in the number of neurological diseases, and rising awareness regarding the benefits offered by neuroendoscopy for diagnosis and treatment of these ailments among others. For instance, according to the Pan American Health Organization data, in 2020, around the mortality rate among individuals suffering from neurological condition in the U.S. was around 47.4 per 100,000 population and is expected to increase in the near future. The higher incidence of these diseases has resulted in the surged number of neuroendoscopy procedures that is anticipated to fuel the product adoption rate thereby, further accelerating the business growth.

Neuroendoscopy Market Share

Some of the major players operating in the neuroendoscopy market are :

• Ackermann Instrumente GmbH
• Adeor medical AG
• Advanced Biologics
• AdvinHealthcare
• B. Braun Melsungen AG
• Chongqing Xishan Science & Technology Co., Ltd.
• Clarus Medical LLC
• KARL STORZ
• Machida Endoscope Co., Ltd.
• Schindlerendoskopie technologie GmbH 
   

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products.
 

Neuroendoscopy Market News:

• In January 2021, ClearMind Biomedical announced that they had received the U.S. FDA for its Axonpen System, a novel neuroendoscope. This neuroendoscope provides illumination and visualization of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during surgery. This regulatory approval helped the company to increase their R&D capabilities and enhance their product portfolio.
   
• In August 2021, Adeor Medical AG annoufnced a strategic partnership with ClearPoint Neuro, Inc. a global therapy-enabling platform company providing navigation and delivery to the brain. This partnership incorporated the distribution of medical devices and equipment intended for neurosurgery by ClearPoint Neuro, Inc. in the U.S. This strategic agreement helped the company to enhance their customer base and increase their business revenue.
   

Neuroendoscopy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million  and Units from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product

• Rigid Neuroendoscopes
  • Rigid Fiberscopes
  • Rigid Videoscopes
• Flexible Neuroendoscopes

By Application

• Transnasal Neuroendoscopy
• Intraventricular Neuroendoscopy
• Transcranial Neuroendoscopy

By Usability

• Reusable Neuroendoscopes
• Disposable Neuroendoscopes

By Patient

• Adult
• Pediatric

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others  

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • The Netherlands
  • Switzerland
  • Sweden
  • Belgium
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Taiwan
  • Malaysia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Iran